Ascendis Pharma A/S (ASND)
234.08
-0.87
(-0.37%)
USD |
NASDAQ |
Feb 24, 15:55
Ascendis Pharma Total Liabilities (Quarterly) : 1.721B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Novo Nordisk A/S | 54.85B |
| Evaxion AS | 14.90M |
| DBV Technologies SA | 57.64M |
| Cellectis SA | 242.57M |
| Biodexa Pharmaceuticals Plc | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.530B |
| Shareholders Equity (Quarterly) | -191.23M |
| Debt to Equity Ratio | -5.354 |
| Current Ratio | 1.037 |
| Net Debt Paydown Yield | -0.22% |